Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001193125-16-533989
Filing Date
2016-04-07
Accepted
2016-04-07 17:17:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 8-A d131257d8a12ga.htm 8-A12G/A 31433
  Complete submission text file 0001193125-16-533989.txt   32750
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-A12G/A | Act: 34 | File No.: 000-21898 | Film No.: 161560784
SIC: 8731 Services-Commercial Physical & Biological Research